Additionally, in human colorectal adenoma and carcinoma cells, PGE2 treatment up-regulated the protein expression of the Wnt target gene, leucine-rich G-protein coupled receptor 5 (LGR5), which internalizes FZD co-receptor LRP6 and decreases Wnt activity [60]. The gene discussed is LGR5; the disease is carcinoma.